Starpharma Holdings EPS - Earnings per Share 2011-2021 | SPHRY

Starpharma Holdings eps - earnings per share from 2011 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Starpharma Holdings Annual EPS
2021 $-0.37
2020 $-0.27
2019 $-0.29
2018 $-0.23
2017 $0.15
2016 $-0.51
2015 $-0.50
2014 $-0.47
2013 $-0.21
2012 $-0.52
2011 $0.00
Starpharma Holdings Quarterly EPS
2021-06-30 $0.00
2020-12-31 $0.00
2020-06-30 $0.00
2019-12-31 $0.00
2019-06-30 $0.00
2018-06-30 $0.00
2017-12-31 $0.00
2017-06-30 $0.00
2016-12-31 $0.00
2016-06-30 $0.00
2015-06-30 $0.00
2014-12-31 $0.00
2014-06-30 $0.00
2013-12-31 $0.00
2013-06-30 $0.00
2012-12-31 $0.00
2012-06-30 $0.00
2011-12-31 $0.00
2011-06-30 $0.00
2010-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.216B $0.002B
Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.213B 9.87
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.280B 16.23
Biohaven Pharmaceutical Holding (BHVN) United States $10.017B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $1.775B 7.60
Arcus Biosciences (RCUS) United States $1.357B 34.40
Myovant Sciences (MYOV) United Kingdom $1.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.360B 0.00
Zymeworks (ZYME) Canada $0.346B 0.00
Ambrx Biopharma (AMAM) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.099B 0.00